Arslan, SevketUcar, RamazanCaliskaner, Ahmet Zafer2024-02-232024-02-2320161308-8742https://doi.org/10.5152/eurasianjmed.2015.0024https://hdl.handle.net/20.500.12452/16696Metamizole, a non-steroidal anti-inflammatory drug with weak anti-inflammatory and spasmolytic effects, is used as an analgesic and antipyretic agent. Many adverse reactions to metamizole, such as early or late-onset systemic reactions and bone marrow suppression, have been identified. In this report, we present a case of systemic reaction after the application of parenteral metamizole (Novalgin (R) ampoule; Sanofi Aventis, Istanbul, Turkey) and discuss the mechanism underlying the reaction.eninfo:eu-repo/semantics/openAccessAbdominal PainMetamizoleSystemic ReactionsArticle482145148275511802-s2.0-84979263812Q3WOS:00038325680001410.5152/eurasianjmed.2015.0024